- $36.13m
- $34.15m
- $4.07m
- 18
- 33
- 94
- 46
Annual income statement for BTCS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 1.21 | 1.69 | 1.34 | 4.07 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.945 | 1.27 | 0.98 | 0.946 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.99 | 19.1 | 6.35 | 5.66 | 13 |
| Operating Profit | -1.99 | -17.9 | -4.65 | -4.32 | -8.93 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.56 | -16 | -15.9 | 7.82 | -1.27 |
| Net Income After Taxes | -2.56 | -16 | -15.9 | 7.82 | -1.27 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.56 | -16 | -15.9 | 7.82 | -1.27 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.56 | -21.1 | -15.9 | 7.82 | -1.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.857 | -2.52 | -1.25 | 0.555 | -0.078 |
| Dividends per Share | |||||
| Special Dividends per Share |